Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance

Por van Tienen, Carla, van de Vijver, David, Noori, Teymur, Sönnerborg, Anders, Boucher, Charles
Publicado no Euro Surveill (2017)

Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam

Por Zhu Yifan, van de Vijver David, Quax Rick, Mei Shan, Sloot P M A
Publicado em 2011-05-01

Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam

Por Mei, Shan, Quax, Rick, van de Vijver, David, Zhu, Yifan, Sloot, P M A
Publicado em 2011

Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention

Por Gupta, Ravindra K, Van de Vijver, David A M C, Manicklal, Sheetal, Wainberg, Mark A
Publicado em 2013

Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria

Por Nijssen, Saskia, Fluit, Ad, van de Vijver, David, Top, Janetta, Willems, Rob, Bonten, Marc J. M.
Publicado em 2009

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort

Por Rokx, Casper, Fibriani, Azzania, van de Vijver, David, Verbon, Annelies, Schutten, Martin, Gras, Luuk, Rijnders, Bart JA
Publicado no J Int AIDS Soc (2014)

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact

Por Dimitrov, Dobromir T., Boily, Marie-Claude, Hallett, Timothy B., Albert, Jan, Boucher, Charles, Mellors, John W., Pillay, Deenan, van de Vijver, David A. M. C.
Publicado no PLoS One (2016)

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study

Por Nichols, Brooke E., Götz, Hannelore M., van Gorp, Eric C. M., Verbon, Annelies, Rokx, Casper, Boucher, Charles A. B., van de Vijver, David A. M. C.
Publicado no PLoS One (2015)

Characterization of the Mouse Neuroinvasiveness of Selected European Strains of West Nile Virus

Por Lim, Stephanie M., Koraka, Penelope, van Boheemen, Sander, Roose, Jouke M., Jaarsma, Dick, van de Vijver, David A. M. C., Osterhaus, Albert D. M. E., Martina, Byron E. E.
Publicado em 2013

Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project

Por Been, Sabrina K., van de Vijver, David A. M. C., Nieuwkerk, Pythia T., Brito, Inês, Stutterheim, Sarah E., Bos, Arjan E. R., Wolfers, Mireille E. G., Pogány, Katalin, Verbon, Annelies
Publicado no PLoS One (2016)

Mutation V111I in HIV-2 Reverse Transcriptase Increases the Fitness of the Nucleoside Analogue-Resistant K65R and Q151M Viruses

Por Deuzing, Ilona P., Charpentier, Charlotte, Wright, David W., Matheron, Sophie, Paton, Jack, Frentz, Dineke, van de Vijver, David A., Coveney, Peter V., Descamps, Diane, Boucher, Charles A. B., Beerens, Nancy
Publicado no J Virol (2014)

Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models

Por Prosperi, Mattia C. F., Rosen-Zvi, Michal, Altmann, André, Zazzi, Maurizio, Di Giambenedetto, Simona, Kaiser, Rolf, Schülter, Eugen, Struck, Daniel, Sloot, Peter, van de Vijver, David A., Vandamme, Anne-Mieke, Sönnerborg, Anders
Publicado em 2010

Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models

Por Prosperi, Mattia C. F., Rosen-Zvi, Michal, Altmann, André, Zazzi, Maurizio, Di Giambenedetto, Simona, Kaiser, Rolf, Schülter, Eugen, Struck, Daniel, Sloot, Peter, van de Vijver, David A., Vandamme, Anne-Mieke, Sönnerborg, Anders
Publicado em 2011

No Serological Evidence that Harbour Porpoises Are Additional Hosts of Influenza B Viruses

Por Bodewes, Rogier, van de Bildt, Marco W. G., van Elk, Cornelis E., Bunskoek, Paulien E., van de Vijver, David A. M. C., Smits, Saskia L., Osterhaus, Albert D. M. E., Kuiken, Thijs
Publicado em 2014

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study

Por Nichols, Brooke E., Boucher, Charles A. B., van Dijk, Janneke H., Thuma, Phil E., Nouwen, Jan L., Baltussen, Rob, van de Wijgert, Janneke, Sloot, Peter M. A., van de Vijver, David A. M. C.
Publicado em 2013

Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study

Por Nichols, Brooke E, Sigaloff, Kim CE, Kityo, Cissy, Hamers, Raph L, Baltussen, Rob, Bertagnolio, Silvia, Jordan, Michael R, Hallett, Timothy B, Boucher, Charles AB, de Wit, Tobias F Rinke, van de Vijver, David AMC
Publicado no J Int AIDS Soc (2014)

Differential Recognition of Influenza A Viruses by M1(58–66) Epitope-Specific CD8(+) T Cells Is Determined by Extraepitopic Amino Acid Residues

Por van de Sandt, Carolien E., Kreijtz, Joost H. C. M., Geelhoed-Mieras, Martina M., Nieuwkoop, Nella J., Spronken, Monique I., van de Vijver, David A. M. C., Fouchier, Ron A. M., Osterhaus, Albert D. M. E., Rimmelzwaan, Guus F.
Publicado no J Virol (2015)

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort

Por Bartha, István, Assel, Matthias, Sloot, Peter MA, Zazzi, Maurizio, Torti, Carlo, Schülter, Eugen, Luca, Andrea De, Sönnerborg, Anders, Abecasis, Ana B, Van Laethem, Kristel, Rosi, Andrea, Svärd, Jenny, Paredes, Roger, van de Vijver, David AMC, Vandamme, Anne-Mieke, Müller, Viktor
Publicado em 2013

Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

Por Munster, Vincent J., de Wit, Emmie, van den Brand, Judith M. A., Herfst, Sander, Schrauwen, Eefje J. A., Bestebroer, Theo M., van de Vijver, David, Boucher, Charles A., Koopmans, Marion, Rimmelzwaan, Guus F., Kuiken, Thijs, Osterhaus, Albert D. M. E., Fouchier, Ron A. M.
Publicado no Science (2009)

Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006

Por van Beek, Janko, de Graaf, Miranda, Xia, Ming, Jiang, Xi, Vinjé, Jan, Beersma, Mathias, de Bruin, Erwin, van de Vijver, David, Holwerda, Melle, van Houten, Marlies, Buisman, Annemarie M., van Binnendijk, Rob, Osterhaus, Albert D. M. E., van der Klis, Fiona, Vennema, Harry, Koopmans, Marion P. G.
Publicado no J Gen Virol (2016)